Igor Losev
Overview
Explore the profile of Igor Losev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desheva Y, Petkova N, Losev I, Guzhov D, Go A, Chao Y, et al.
Int J Mol Sci
. 2023 Feb;
24(3).
PMID: 36768700
Neuraminidase (NA)-based immunity to influenza can be useful for protecting against novel antigenic variants. To develop safe and effective tools to assess NA-based immunity, we generated a baculovirus-based pseudotyped virus,...
2.
Desheva Y, Losev I, Petkova N, Kudar P, Donina S, Mamontov A, et al.
Pharmaceuticals (Basel)
. 2022 Sep;
15(9).
PMID: 36145348
Influenza outbreaks caused by A/H7N9 viruses have occurred since 2013. After 2016, A/H7N9 influenza viruses underwent evolutionary changes. In this study, we examined the antigenic properties of influenza neuraminidase (NA)...
3.
Desheva Y, Leontieva G, Kramskaya T, Losev I, Rekstin A, Petkova N, et al.
Microorganisms
. 2022 Jun;
10(6).
PMID: 35744668
Influenza and infections are a significant cause of morbidity and mortality worldwide. Intranasal live influenza vaccine (LAIV) may prevent influenza-related bacterial complications. The objectives of the study are to estimate...
4.
Desheva Y, Leontieva G, Kramskaya T, Losev I, Petkova N, Rekstin A, et al.
Virulence
. 2022 Mar;
13(1):558-568.
PMID: 35266442
Severe influenza complications are often caused by infection, which presents the most common cause of community-acquired pneumonia. We evaluated in a mouse model an associated virus-bacterial vaccine based on seasonal...
5.
Desheva Y, Leontieva G, Kramskaya T, Gupalova T, Losev I, Kuleshevich E, et al.
Microorganisms
. 2021 Dec;
9(12).
PMID: 34946050
Probiotic microorganisms are currently considered as a promising platform for the development of recombinant vaccines expressing foreign antigens. In this study, we generated and evaluated the live mucosal recombinant vaccine...
6.
Mamontov A, Losev I, Korzhevskii D, Guselnikova V, Polevshchikov A, Desheva Y
Front Immunol
. 2021 Aug;
12:689436.
PMID: 34335593
We investigated the reaction of mouse peritoneal mast cells (MCs) after IgG-containing immune complex introduction using A/H5N1 and A/H1N1pdm09 influenza viruses as antigens. The sera of immune mice served as...
7.
Rekstin A, Isakova-Sivak I, Petukhova G, Korenkov D, Losev I, Smolonogina T, et al.
Biomed Res Int
. 2017 Feb;
2017:9359276.
PMID: 28210631
Since conserved viral proteins of influenza virus, such as nucleoprotein (NP) and matrix 1 protein, are the main targets for virus-specific CD8+ cytotoxic T-lymphocytes (CTLs), we hypothesized that introduction of...
8.
Rudenko L, Naykhin A, Donina S, Korenkov D, Petukhova G, Isakova-Sivak I, et al.
Hum Vaccin Immunother
. 2015 Dec;
11(12):2839-48.
PMID: 26697973
During the past decade, a number of H5 subtype influenza vaccines have been developed and tested in clinical trials, but most of them induced poor serum antibody responses prompting the...